Panacea Life Sciences Stock Net Income
| PLSH Stock | USD 0.04 0 9.18% |
As of the 28th of January, Panacea Life holds the Coefficient Of Variation of 5381.68, risk adjusted performance of 0.0232, and Semi Deviation of 9.68. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Panacea Life, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Panacea Life Sciences, which can be compared to its competitors.
Panacea Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Panacea Life's valuation are provided below:Panacea Life Sciences does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Panacea |
Panacea Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Panacea Life's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Panacea Life.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Panacea Life on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Panacea Life Sciences or generate 0.0% return on investment in Panacea Life over 90 days. Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, de... More
Panacea Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Panacea Life's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Panacea Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 22.72 | |||
| Information Ratio | 0.013 | |||
| Maximum Drawdown | 94.5 | |||
| Value At Risk | (27.55) | |||
| Potential Upside | 28.0 |
Panacea Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Panacea Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Panacea Life's standard deviation. In reality, there are many statistical measures that can use Panacea Life historical prices to predict the future Panacea Life's volatility.| Risk Adjusted Performance | 0.0232 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (1.08) | |||
| Sortino Ratio | 0.0081 | |||
| Treynor Ratio | 0.0594 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Panacea Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Panacea Life January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0232 | |||
| Market Risk Adjusted Performance | 0.0694 | |||
| Mean Deviation | 6.73 | |||
| Semi Deviation | 9.68 | |||
| Downside Deviation | 22.72 | |||
| Coefficient Of Variation | 5381.68 | |||
| Standard Deviation | 14.18 | |||
| Variance | 201.18 | |||
| Information Ratio | 0.013 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (1.08) | |||
| Sortino Ratio | 0.0081 | |||
| Treynor Ratio | 0.0594 | |||
| Maximum Drawdown | 94.5 | |||
| Value At Risk | (27.55) | |||
| Potential Upside | 28.0 | |||
| Downside Variance | 516.41 | |||
| Semi Variance | 93.62 | |||
| Expected Short fall | (22.48) | |||
| Skewness | 1.17 | |||
| Kurtosis | 6.46 |
Panacea Life Sciences Backtested Returns
Panacea Life appears to be out of control, given 3 months investment horizon. Panacea Life Sciences maintains Sharpe Ratio (i.e., Efficiency) of 0.0193, which implies the firm had a 0.0193 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Panacea Life Sciences, which you can use to evaluate the volatility of the company. Please evaluate Panacea Life's Coefficient Of Variation of 5381.68, semi deviation of 9.68, and Risk Adjusted Performance of 0.0232 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Panacea Life holds a performance score of 1. The company holds a Beta of 4.27, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Panacea Life will likely underperform. Please check Panacea Life's maximum drawdown, as well as the relationship between the expected short fall and day typical price , to make a quick decision on whether Panacea Life's historical price patterns will revert.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Panacea Life Sciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Panacea Life time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Panacea Life Sciences price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Panacea Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Panacea Life Sciences reported net income of (4.78 Million). This is 101.4% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.84% higher than that of the company.
Panacea Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Panacea Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Panacea Life could also be used in its relative valuation, which is a method of valuing Panacea Life by comparing valuation metrics of similar companies.Panacea Life is currently under evaluation in net income category among its peers.
Panacea Fundamentals
| Return On Equity | -2.4 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (3.30) % | |||
| Current Valuation | 18.03 M | |||
| Shares Outstanding | 14.97 M | |||
| Shares Owned By Insiders | 62.88 % | |||
| Price To Book | 0.46 X | |||
| Price To Sales | 0.55 X | |||
| Revenue | 2.06 M | |||
| Gross Profit | (4.42 M) | |||
| EBITDA | (2.71 M) | |||
| Net Income | (4.78 M) | |||
| Cash And Equivalents | 2.6 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 3.26 M | |||
| Debt To Equity | 7.61 % | |||
| Current Ratio | 0.62 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (3.92 M) | |||
| Earnings Per Share | (0.46) X | |||
| Number Of Employees | 29 | |||
| Market Capitalization | 3.33 M | |||
| Total Asset | 23.78 M | |||
| Z Score | 0.6 | |||
| Net Asset | 23.78 M |
About Panacea Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Panacea Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Panacea Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Panacea Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Panacea OTC Stock
Panacea Life financial ratios help investors to determine whether Panacea OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Panacea with respect to the benefits of owning Panacea Life security.